Core Viewpoint - The announcement indicates that TianKang's wholly-owned subsidiary, Huabo Kaisheng, has received drug registration certificates for Minoxidil topical solution from the National Medical Products Administration, marking a significant step in the company's product offerings in the hair loss treatment market [1] Group 1: Company Developments - Huabo Kaisheng has been granted registration for Minoxidil topical solution in two formulations: 60ml:1.2g and 60ml:3.0g, with approval numbers H20263325 and H20263326 respectively [1] - The product's sales performance is subject to various influencing factors, indicating potential variability in market reception and revenue generation [1] Group 2: Industry Insights - The domestic market for hair loss prevention is projected to grow, with 31 companies currently holding registration for Minoxidil topical solution in China, highlighting a competitive landscape [1]
泰恩康：全资子公司收到米诺地尔搽剂药品注册证书